Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Markets & Finance

Alternative Power Stocks Soar

With the electrical grid in the eastern U.S. crippled by the power outage, stocks of companies that provide provide power protection products and services did well in Friday's market. Among the big gainers in the group: American Superconductor (AMSC), FuelCell Energy (FCEL), Plug Power (PLUG), Ballard Power (BLDP), and American Power Conversion (APCC).

After the close of trading Thursday, PC giant Dell Computer (DELL) released second quarter results. The company posted EPS of 24 cents vs. 19 cents one year earlier as revenues rose 16% to $9.8 billion. Dell forecast third quarter EPS of 26 cents on $10.5 billion in revenues. S&P reiterated its hold opinion on the shares while AG Edwards upgraded Dell to buy from hold.

Protein Design Labs (PDLI) shares fell after the company said it had not reached a deal yet in talks with Genentech (DNA) on whether Genentech's humanized antibody, Xolair, requires a license under Protein Design's fundamental antibody humanization patents.

Advanced Digital (ADIC) shares rose after the company posted third quarter EPS of 4 cents vs. a 3-cent loss per share one year earlier on a 42% sales rise. Bear Stearns upgraded the shares to outperform from peer perform.

Kohl's (KSS) shares moved higher after the company reported second quarter EPS of 33 cents vs. 36 cents despite 1.1% higher second-quarter same store sales and 15% higher net sales.

Analog Devices (ADI) moved lower after the company posted third quarter EPS of 21 cents vs. 8 cents (GAAP basis) on a 17% revenue rise. Citigroup downgraded the shares to in line from outperform. S&P reiterated its buy ranking.

Neose Technologies (NTEC) gained after the company agreed to use its technologies with a therapeutic recombinant protein that is produced and supplied by Sandoz. Neose says both companies may end up with co-exclusive worldwide rights if further development takes place.

blog comments powered by Disqus